REMEDI group is dedicated to advancing the next generation of autologous micrograft therapies.
Formed in 2024 through the strategic merger of Human Brain Wave SRL and Regenera Activa SL, REMEDI group unites pioneering forces in regenerative medicine with a shared commitment to innovation, scientific rigor, and patient-centered solutions.
Human Brain Wave, founded in 2012, patented the Rigenera micrograft technology a device designed for the disaggregation of autologous tissue, obtaining a suspension rich in growth factors, supporting regeneration. Regenera Activa, founded in 2015, expanded the clinical applications of this technology, developing innovative medical treatments supported by extensive expertise in biomedical research and regenerative medicine
Currently, REMEDI group leverages this combined legacy to deliver high-quality, clinically validated medical devices across multiple therapeutic fields. Our specialized medical devices address a broad range of disciplines — including wound healing, dermatology, oral surgery, and musculoskeletal medicine — ensuring clinicians have access to advanced, minimally invasive regenerative options tailored to their practice.
Contact us
Mytocel MSK is REMEDI’s orthopaedic and joint-health division, focused on improving outcomes for patients with osteoarthritis, cartilage injuries and conditions as chondromalacia, tendinopathies and other musculoskeletal disorders.
At Remedi we pursue revolutionizing healthcare by offering doctors pioneering, safe, effective and minimally invasive cell regenerative solutions, leveraging cutting-edge technologies to elevate medical standards and transform lives through the limitless possibilities of cellular regeneration.
At Remedi, our mission involves providing doctors with cutting-edge cell regenerative medical solutions, emphasizing minimally invasive procedures to optimize precision, effectiveness and safety. Through relentless innovation and scientific leadership, we aim to redefine medical standards, empower healthcare professionals, and transform lives by unlocking the full potential of cellular regeneration.
Regional Office
Regional Office
Regional Office
Regional Office
Our technology and manufacturing processes are developed to ensure clinical reproducibility and regulatory compliance within the medical device framework.
Production under controlled European medical device standards.
Designed and distributed according to CE regulatory requirements.
Technologies designed exclusively for trained healthcare professionals.